Ventfort 20mg
Natural vascular tissue peptide bioregulator investigated for microvascular integrity, endothelial function, and cellular renewal.
Mechanism
Proposed to act as a tissue-specific vascular bioregulator that modulates gene expression and promotes structural protein synthesis in endothelial and vascular wall cells.
Dosing
Standard investigational regimens begin with 20 mg (one capsule) once daily administered across an uninterrupted 10 to 30 day cycle.
Reconstitution
Supplied as an oral capsule requiring no reconstitution or dilution with bacteriostatic water.
Storage
Store sealed in a dry, dark place at controlled room temperature away from excessive moisture and thermal degradation.
Mix & measure Ventfort 20mg
Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.
Mix & measure Ventfort 20mg
Vial strength → BAC water → target dose
Common vial sizes
Label claim
Total doses in vial: —
U-100 syringe: 100 units = 1 mL
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →
Track my protocol
Log each dose, build a streak, and watch your progress through this protocol's schedule.
Dosing Chart
| Phase / Day(s) | Dose & Frequency | Volume (U-100 units / mL) |
|---|---|---|
| Initiation (Days 1–10) | 20 mg (1 capsule) once daily | Oral capsule (N/A) |
| Standard Course (Days 11–30) | 20–40 mg (1–2 capsules) once daily | Oral capsule (N/A) |
| Maintenance Interval | 0 mg (Multi-month gap between courses) | None |
Reconstitution Steps
- 1
Verify the integrity of the packaging and confirm the 20 mg capsule unit strength.
- 2
Do not reconstitute or combine with bacteriostatic fluids as the compound is formulated for oral administration.
- 3
Administer the whole capsule with water approximately 15 to 20 minutes prior to a meal.
- 4
Maintain daily adherence throughout the designated 10 to 30 day observation period.
- 5
Securely close the primary packaging and maintain dry room-temperature storage between scheduled doses.
Supplies Needed
Peptide Vial
Supplied as intact 20 mg oral capsules of natural vascular peptide extract
Insulin Syringes (U-100)
Not required; protocol utilizes oral capsule administration
Bacteriostatic Water
Not required; compound is not reconstituted for injection
Alcohol Swabs
Not required for oral dosing protocols
Why researchers study it
Vascular and endothelial tissue maintenance
Hemodynamic parameters and peripheral circulation
Microvascular cellular repair in aging models
Biological comparison to the synthetic tripeptide Vesugen
These describe what is being studied, not proven benefits, approved uses, or promised results.
Overview
Ventfort is an animal-derived peptide bioregulator classified within the Cytomax family (code A-3), originally isolated from the blood vessel tissue of young calves. In classical bioregulatory theory, short organ-specific peptide fractions interact with cellular DNA to support tissue-selective protein synthesis and maintain homeostatic cellular turnover within the vascular endothelium and vascular smooth muscle layers. While scientific literature surrounding the synthetic tripeptide analog Vesugen (Lys-Glu-Asp) demonstrates specific parameters in microvascular restoration and hemodynamic flow, Ventfort remains an unstandardized, proprietary natural peptide extract. Research protocols generally evaluate its systemic biological impact as a non-injectable, oral dietary compound or laboratory specimen rather than a synthesized single-target pharmaceutical.
References
- 1.Khavinson, Neuroendocrinology Letters, 2002 — Peptides and Ageing
- 2.Kitachev et al., Advances in Gerontology, 2014 — Efficacy of peptide bioregulators of vessels in chronic lower-limb arterial insufficiency in the elderly
- 3.Ryzhak et al., Advances in Gerontology, 2008 — Peptidergic regulation of pancreas function in accelerated-aging rats
- 4.Khavinson et al., Advances in Gerontology, 2013 — Peptide bioregulators: a new class of geroprotectors (clinical studies results)
Supplies Needed
Suggested supplier
Research use only. Listing a supplier is not an endorsement of any protocol on this site, and nothing sold there is approved for human use.
Related protocols
View allKPV 10mg
KPV is an alpha-MSH-derived C-terminal tripeptide studied for NF-kB suppression, mucosal healing, and inflammatory modulation.
View ProtocolTB-500 + BPC-157 5+5 mg
A dual-peptide research stack pairing TB-500 and BPC-157 in separate vials to investigate complementary soft-tissue and wound healing pathways.
View ProtocolGDF-8 / Myostatin 1mg
Laboratory reference ligand that functions as an endogenous negative regulator of skeletal muscle hypertrophy and tissue growth.
View Protocol